Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qiagen (QGEN) Short term Debt (2018 - 2025)

Qiagen's Short term Debt history spans 15 years, with the latest figure at $499.6 million for Q3 2025.

  • On a quarterly basis, Short term Debt fell 10.02% to $499.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $499.6 million, a 10.02% decrease, with the full-year FY2024 number at $551.9 million, down 6.14% from a year prior.
  • Short term Debt hit $499.6 million in Q3 2025 for Qiagen, down from $559.2 million in the prior quarter.
  • Over the last five years, Short term Debt for QGEN hit a ceiling of $866.0 million in Q3 2022 and a floor of $100.6 million in Q3 2023.
  • Historically, Short term Debt has averaged $517.0 million across 5 years, with a median of $500.1 million in 2023.
  • Biggest five-year swings in Short term Debt: surged 1892.59% in 2021 and later crashed 88.38% in 2023.
  • Tracing QGEN's Short term Debt over 5 years: stood at $847.6 million in 2021, then tumbled by 54.04% to $389.6 million in 2022, then surged by 50.93% to $588.0 million in 2023, then decreased by 6.14% to $551.9 million in 2024, then decreased by 9.47% to $499.6 million in 2025.
  • Business Quant data shows Short term Debt for QGEN at $499.6 million in Q3 2025, $559.2 million in Q2 2025, and $554.2 million in Q1 2025.